Navigation Links
From microscope to stethoscope: The MUHC's public lecture series begins its 2nd season tomorrow
Date:10/2/2007

Montreal, October 2nd, 2007 - From Microscope to Stethoscope, the distinguished public lecture series organized by the Research Institute of the McGill University Health Centre (MUHC), is embarking on its second season tomorrow.

For this opening conference, Dr. Vassilios Papadopoulos, Director of the Research Institute of the MUHC, will be sharing the hope that his current research may bring to patients suffering from Alzheimers disease. Alzheimers disease is one of the most devastating neurodegenerative pathologies, for both patients and families; unfortunately its origins are still a mystery, explains Dr Papadopoulos. His latest laboratory findings could lead to remarkable therapeutic advances and relieve the difficulties doctors currently have in terms of diagnosis and treatment.

The second lecture will be given on Monday, November 7, 2007, by Dr. Lawrence Rosenberg, a world expert in diabetes, and the third one will be by Dr. Ronald Olivenstein, MUHC Asthma Clinic Director, on Wednesday, December 3, 2007.

"Again this year, three of our most brilliant researchers invite you on a journey into a possible future, when current research has already turned into innovative treatments for patients, declared Dr. Arthur T. Porter, Director General of the MUHC. These lectures will give you a direct look at the intellectual vitality that fills our research laboratories and the enormous impact of this work on our daily lives.

The lectures will take place at the Montreal General Hospital in Livingston Hall (Rom L6-500) starting at 7:30 p.m. Admission is free and anyone interested is welcome.

The speakers will take questions from audience members during a discussion period following each lecture.


'/>"/>

Contact: Isabelle Kling
isabelle.kling@muhc.mcgill.ca
514-934-1934
McGill University Health Centre
Source:Eurekalert

Page: 1

Related medicine news :

1. Controversial deal on public access of the human genome map
2. Defibrillators In Public Places Will Help Cardiac Patients
3. WHO To Support Public Health Threats
4. Public Defibrillators Found To Improve Survival Rate
5. FDA Issues Public Health Advisory on Tysabri, a New Drug for MS
6. WHO Steps Up To Create A Public Awareness About The Consequences Of Exposure To Radon
7. Disaster Planning Guide From Harvard Health Publications
8. India to maintain Public domain Registry database of clinical trials conducted in India.
9. Smoking Ban Believed To Enjoy Widespread Public Acceptance In Scotland
10. Evidences that Better Health Care Facility is Offered By Public Hospitals.
11. UK public misled over downgrading cannabis: Govt
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2016)... Bay, Jamaica (PRWEB) , ... April 30, 2016 ... ... University, and Duane Boise, President and CEO of EMED, today signed a multifaceted ... Jamaica. , EMED and the Northern Caribbean University Department of Natural and Applied ...
(Date:4/30/2016)... ... April 30, 2016 , ... Orlando-based Maximized Living has selected Dr. ... gold in Rio. Under the care of Maximized Living doctors at the London ... unprecedented showing, Maximized Living is sending the largest contingent of elite chiropractors to Rio ...
(Date:4/29/2016)... ... 2016 , ... In an article published April 16th on the ... and lip injections, which she underwent in order to feel more at home at ... Festival. The article explains that Ms. Mirmelli’s situation is not unique; many plastic surgeons ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... , announces the addition Onnit brand Alpha BRAIN and New Mood Daily-Stress Formula ... brain and mood optimization products to the store is just one more way ...
(Date:4/29/2016)... ... April 29, 2016 , ... The American workforce is ... even security. Most importantly, employees are the single most important asset in creating ... so unhappy? , Just under half of American workers are emotionally checked out ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... April 28, 2016 Treato ... on healthcare, announced today that it has been named ... Cool Vendor in Life Sciences, 2016, Stephen ...  The report focuses on life-science- oriented analytics, algorithms and ... patients and doctors, confirm medication ingestion, and analyze unstructured ...
(Date:4/28/2016)... , April 28, 2016 Oramed ... a clinical-stage pharmaceutical company focused on the development of oral ... in the upcoming PIONEERS 2016 conference, presented by Joseph ... 2016 in New York . Nadav ... at the conference. Presentation Details:   ...
(Date:4/28/2016)... -- TapImmune,Inc. (TPIV), a clinical-stage immune-oncology ... immunotherapeutics and vaccines for the treatment of cancer & metastatic ... Annual Growth Capital Expo to be held on May ... Palace in Las Vegas, Nevada.  The Company presentation will ... by Dr. John N. Bonfiglio a TapImmune ...
Breaking Medicine Technology: